MetaStat To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum On October 8 In San Francisco

BOSTON--(BUSINESS WIRE)--MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on understanding and treating systemic metastasis, announced that Oscar L. Bronsther, M.D., Chief Executive Officer, is scheduled to speak at the 13th Annual BIO Investor Forum on October 8, 2014 at 2:00 pm PDT in San Francisco. Dr. Bronsther will provide an update on the Company’s business activities.

MetaStat’s presentation will be held in the Presidio Room of the Palace Hotel in San Francisco. A live, listen-only audio webcast will be available at:

http://www.veracast.com/webcasts/bio/investorforum2014/55210199361.cfm

Help employers find you! Check out all the jobs and post your resume.

Back to news